Literature DB >> 5896942

New treatment schedule with improved survival in childhood leukemia. Intermittent parenteral vs daily oral administration of methotrexate for maintenance of induced remission. Acute leukemia group B.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5896942

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  Clinical pharmacokinetics of methotrexate.

Authors:  D D Shen; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 2.  Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Alkylating agent resistance: in vitro studies with human cell lines.

Authors:  E Frei; C A Cucchi; A Rosowsky; R Tantravahi; S Bernal; T J Ervin; R M Ruprecht; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  [Clinico-pharmacologic, cytochemical and Feulgen photometric studies in adult undifferentiated cell leukemias under combination chemotherapy with vincristine, daunorubicine and prednisone].

Authors:  P Obrecht; H Merker; H H Hennekeuser; G Meuret; M Westerhausen; A Simon
Journal:  Klin Wochenschr       Date:  1970-11-01

Review 5.  Chemotherapy of acute leukemia in childhood.

Authors:  K K Khanna
Journal:  Indian J Pediatr       Date:  1968-12       Impact factor: 1.967

6.  Multiclinic trials in cancer chemotherapy.

Authors:  C G Zubrod
Journal:  Can Med Assoc J       Date:  1967-07-15       Impact factor: 8.262

7.  Some problems in the management of leukaemia and lymphoma.

Authors:  D A Galton
Journal:  Proc R Soc Med       Date:  1966-12

8.  Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia.

Authors:  J D Borsi; T Revesz; D Schuler
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.